195 related articles for article (PubMed ID: 34898295)
1. The Impact of Anticoagulant Activity of Tissue Factor Pathway Inhibitor Measured by a Novel Functional Assay for Predicting Deep Venous Thrombosis in Trauma Patients: A Prospective Nested Case-Control Study.
Cao X; Su Y; Zhang W; Zhao H; Wen M; Lu S; Zhao Y; Chen Y; Liu L; Zang X; Wu J
Clin Appl Thromb Hemost; 2021; 27():10760296211063877. PubMed ID: 34898295
[TBL] [Abstract][Full Text] [Related]
2. Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer.
Fei X; Wang H; Yuan W; Wo M; Jiang L
Biomed Res Int; 2017; 2017():8983763. PubMed ID: 28246607
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state.
Dahm A; Rosendaal FR; Andersen TO; Sandset PM
Br J Haematol; 2006 Feb; 132(3):333-8. PubMed ID: 16409298
[TBL] [Abstract][Full Text] [Related]
4. Poor anticoagulant response to tissue factor pathway inhibitor in patients with venous thrombosis.
Tardy-Poncet B; Tardy B; Laporte S; Mismetti P; Amiral J; Piot M; Reynaud J; Campos L; Decousus H
J Thromb Haemost; 2003 Mar; 1(3):507-10. PubMed ID: 12871458
[TBL] [Abstract][Full Text] [Related]
5. Coagulation Factor Hyperfunction After Subarachnoid Hemorrhage Induces Deep Venous Thrombosis.
Miao W; Zhao K; Deng W; Teng J
World Neurosurg; 2018 Feb; 110():e46-e52. PubMed ID: 29196248
[TBL] [Abstract][Full Text] [Related]
6. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.
Dahm A; Van Hylckama Vlieg A; Bendz B; Rosendaal F; Bertina RM; Sandset PM
Blood; 2003 Jun; 101(11):4387-92. PubMed ID: 12560220
[TBL] [Abstract][Full Text] [Related]
7. Platelet factor 4 and β-thromboglobulin mRNAs in circulating microparticles of trauma patients as diagnostic markers for deep vein thrombosis.
Su Y; Chen Y; Zhang W; Liu L; Cao X; Wu J
J Thromb Thrombolysis; 2020 Oct; 50(3):525-532. PubMed ID: 32347511
[TBL] [Abstract][Full Text] [Related]
8. Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology.
Zakai NA; Lutsey PL; Folsom AR; Heckbert SR; Cushman M
Thromb Haemost; 2010 Aug; 104(2):207-12. PubMed ID: 20431849
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis.
Amini-Nekoo A; Futers TS; Moia M; Mannucci PM; Grant PJ; Ariëns RA
Br J Haematol; 2001 May; 113(2):537-43. PubMed ID: 11380428
[TBL] [Abstract][Full Text] [Related]
10. Decreased anticoagulant response to tissue factor pathway inhibitor in patients with venous thromboembolism and otherwise no evidence of hereditary or acquired thrombophilia.
Bombeli T; Piccapietra B; Boersma J; Fehr J
Thromb Haemost; 2004 Jan; 91(1):80-6. PubMed ID: 14691572
[TBL] [Abstract][Full Text] [Related]
11. Deep venous thrombosis and ABO blood group are unrelated in trauma patients.
Carter YM; Caps MT; Meissner MH
J Trauma; 2002 Jan; 52(1):112-6. PubMed ID: 11791060
[TBL] [Abstract][Full Text] [Related]
12. A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI).
Dahm AE; Andersen TO; Rosendaal F; Sandset PM
J Thromb Haemost; 2005 Apr; 3(4):651-8. PubMed ID: 15842349
[TBL] [Abstract][Full Text] [Related]
13. Correlation of missed doses of enoxaparin with increased incidence of deep vein thrombosis in trauma and general surgery patients.
Louis SG; Sato M; Geraci T; Anderson R; Cho SD; Van PY; Barton JS; Riha GM; Underwood S; Differding J; Watters JM; Schreiber MA
JAMA Surg; 2014 Apr; 149(4):365-70. PubMed ID: 24577627
[TBL] [Abstract][Full Text] [Related]
14. Association of Asn221Ser mutation in tissue factor pathway inhibitor-beta with plasma total tissue factor pathway inhibitor level.
Ishikawa J; Okada H; Kato H; Takeshita S; Honda S; Kawasaki T; Suehisa E; Tsuji H; Madoiwa S; Sakata Y; Kojima T; Murata M; Ikeda Y; Kokubo Y; Okamura T; Tomoike H; Miyata T
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):22-6. PubMed ID: 20523161
[TBL] [Abstract][Full Text] [Related]
15. Hypercoagulability after trauma: hemostatic changes and relationship to venous thromboembolism.
Selby R; Geerts W; Ofosu FA; Craven S; Dewar L; Phillips A; Szalai JP
Thromb Res; 2009 Jul; 124(3):281-7. PubMed ID: 19041119
[TBL] [Abstract][Full Text] [Related]
16. Aspirin as added prophylaxis for deep vein thrombosis in trauma: A retrospective case-control study.
Brill JB; Calvo RY; Wallace JD; Lewis PR; Bansal V; Sise MJ; Shackford SR
J Trauma Acute Care Surg; 2016 Apr; 80(4):625-30. PubMed ID: 26808030
[TBL] [Abstract][Full Text] [Related]
17. Analysis of perioperative risk factors for deep vein thrombosis in patients with femoral and pelvic fractures.
Wu L; Cheng B
J Orthop Surg Res; 2020 Dec; 15(1):597. PubMed ID: 33302974
[TBL] [Abstract][Full Text] [Related]
18. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG
Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106
[TBL] [Abstract][Full Text] [Related]
19. Positive blood alcohol is associated with reduced DVT in trauma.
Cook MR; Louis SG; McCully SP; Stucke RS; Fabricant SP; Schreiber MA
Injury; 2015 Jan; 46(1):131-5. PubMed ID: 25311264
[TBL] [Abstract][Full Text] [Related]
20. Early thrombin formation capacity in trauma patients and association with venous thromboembolism.
Voils SA; Lemon SJ; Jordan J; Riley P; Frye R
Thromb Res; 2016 Nov; 147():13-15. PubMed ID: 27664391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
